These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6765547)

  • 1. Different counterregulatory responses to human insulin (recombinant DNA) and purified pork insulin.
    Schlüter KJ; Petersen KG; Sontheimer J; Enzmann F; Kerp L
    Diabetes Care; 1982; 5 Suppl 2():78-81. PubMed ID: 6765547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does insulin species modify counterregulatory hormone response to hypoglycemia?
    Jones TW; Caprio S; Diamond MP; Hallarman L; Boulware SD; Sherwin RS; Tamborlane WV
    Diabetes Care; 1991 Aug; 14(8):728-31. PubMed ID: 1954809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Less pronounced changes in serum potassium and epinephrine during hypoglycemia induced by human insulin (recombinant DNA).
    Petersen KG; Schlüter KJ; Kerp L
    Diabetes Care; 1982; 5 Suppl 2():90-2. PubMed ID: 6765549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers.
    Jacobs MA; Salobir B; Popp-Snijders C; Ader H; Heine RJ
    Diabet Med; 1997 Mar; 14(3):248-57. PubMed ID: 9088775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA).
    Müller-Esch G; von der Lühe C; Ball P; Henkel E; Schlüter KJ; Wood WG; Scriba PC
    Horm Metab Res Suppl; 1988; 18():24-33. PubMed ID: 2847967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the counterregulatory hormone response to semisynthetic human insulin and purified porcine insulin in normal subjects and patients with type I diabetes mellitus.
    LeRoith D; Shemer J; Pickens W; Leslie N; Sperling M; Berelowitz M
    Clin Ther; 1991; 13(5):613-26. PubMed ID: 1799919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies on intermediary metabolism and hormonal counterregulation following human insulin (recombinant DNA) and purified pork insulin in man.
    Rosak C; Althoff PH; Enzmann F; Schöffling K
    Diabetes Care; 1982; 5 Suppl 2():82-9. PubMed ID: 6765548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin.
    Kerr D; Tamborlane WV; Rife F; Sherwin RS
    J Clin Invest; 1993 Jan; 91(1):141-7. PubMed ID: 8423214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of human insulin of recombinant DNA origin in healthy volunteers.
    Ebihara A; Kondo K; Ohashi K; Kosaka K; Kuzuya T; Tarui S
    Diabetes Care; 1982; 5 Suppl 2():35-8. PubMed ID: 6765537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
    Kinsley BT; Simonson DC
    J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of human insulin (recombinant DNA)--regular, NPH, and mixtures--obtained by the Gerritzen method in healthy volunteers.
    Weinges K; Ehrhardt M; Nell G; Enzmann F
    Diabetes Care; 1982; 5 Suppl 2():67-70. PubMed ID: 6765545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthetic human insulin: pharmacokinetics and effects in healthy human volunteers.
    Brogard JM; Blickle JF; Pinget M; Stahl A; Dorner M
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):575-80. PubMed ID: 6360919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counterregulatory hormone release after human and porcine insulin in healthy subjects and patients with pituitary disorders.
    Landgraf-Leurs MM; Brügelmann I; Kammerer S; Lorenz R; Landgraf R
    Klin Wochenschr; 1984 Jul; 62(14):659-68. PubMed ID: 6381871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal counterregulatory responses to human (semi-synthetic and recombinant DNA) and porcine insulin induced hypoglycaemia.
    Owens DR; Vora JP; Tronier B; Keller U; Luzio S; Turkes A
    Diabetes Res; 1988 May; 8(1):17-20. PubMed ID: 3066561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholamine response during human and pork insulin-induced hypoglycemia in IDDM patients.
    Lingenfelser T; Renn W; Plonz C; Radjaipour M; Eggstein M; Jakober B
    Diabetes Care; 1992 Feb; 15(2):261-4. PubMed ID: 1547683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of human and animal insulin on the responses to hypoglycemia in elderly patients with NIDDM.
    Meneilly GS; Milberg WP; Tuokko H
    Diabetes; 1995 Mar; 44(3):272-7. PubMed ID: 7883113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemia following insulin and proinsulin. A comparison.
    Petersen KG; Licht T; Storch M; Pilot PR; Alexopoulos A; Lehmann M; Weigel S; Kerp L
    Horm Metab Res; 1986 Aug; 18(8):530-4. PubMed ID: 3530932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous insulin infusion to simulate subcutaneous absorption. Bioavailability and metabolic sequelae.
    Watanabe RM; Vølund A; Bergman RN
    Diabetes Care; 1991 Nov; 14(11):1021-30. PubMed ID: 1797482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin concentrations and time-action profiles of three different intermediate-acting insulin preparations in nondiabetic volunteers under glucose-controlled glucose infusion technique.
    Bottermann P; Gyaram H; Wahl K; Ermler R; Lebender A
    Diabetes Care; 1982; 5 Suppl 2():43-52. PubMed ID: 6765540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.